ascopubs.org

Effect of first-line modified schedule of gemcitabine on clinical benefit rate and toxicity in elderly or PS 2 patients with advanced non-small cell lung cancer.

Lung cancer survival with herbal medicine and vitamins: Ten-year follow-up. Background: Monochemotherapy with gemcitabine (Gem) is often the treatment of choice in elderly or poor performance status ...
ascopubs.org

A phase II study of gefitinib (G) versus carboplatin and gemcitabine (CG) in chemotherapy-naïve patients with advanced non-small cell lung cancer (NSCLC) and ECOG performance ...

Simulation of phase III studies of motesanib 125 mg once daily (QD) plus carboplatin/paclitaxel (CPM) or bevacizumab plus carboplatin/paclitaxel (CPB) versus ...